Morepen gets USFDA nod for Anti-Allergy Fexofinadine Drug
Summary : Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug fexofinadine hydrochloride Fexofinadine is most widely used, second generation…
Summary : Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug fexofinadine hydrochloride Fexofinadine is most widely used, second generation…
Synopsis- Ichnos Sciences, Glenmark’s drug discovery subsidiary based in the US, on Tuesday said it has entered into an exclusive agreement with…
Synopsis- MS Pharma has signed an exclusive licensing and supply agreement with Bioeq AG, Switzerland to commercialize the biosimilar candidate FYB201 (Ranibizumab)…
Summary – The three-day National Summit on Agro and Food Processing with focus on natural farming will kick start from December 14.…
Summary – The U.S. drugmaker will pay $100 a share in an all-cash transaction for San Diego-based Arena, bringing assets in gastroenterology,…
Synopsis- Alembic said it has acquired preferred stock in RIGImmune amounting to a 19.97% post-money stake in the first closing of the…
Synopsis Dr Reddy’s Valsartan Tablets are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and…
Summary : Alembic said it has so far received 15 product approvals this year. Alembic Pharma received approval from the US health…
Summary : SPARC has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of…
Italian drugmaker Recordati has agreed on a price for six-year-old EUSA Pharma. The Milan-based firm will pay €750m ($845 million) for EUSA’s…